MARTINA, Emanuela
 Distribuzione geografica
Continente #
NA - Nord America 4.606
AS - Asia 1.667
EU - Europa 1.638
SA - Sud America 393
Continente sconosciuto - Info sul continente non disponibili 144
AF - Africa 128
OC - Oceania 5
Totale 8.581
Nazione #
US - Stati Uniti d'America 4.475
SG - Singapore 507
IT - Italia 406
VN - Vietnam 373
RU - Federazione Russa 324
CN - Cina 316
BR - Brasile 310
HK - Hong Kong 179
IE - Irlanda 156
SE - Svezia 148
FR - Francia 135
DE - Germania 107
UA - Ucraina 97
GB - Regno Unito 69
CI - Costa d'Avorio 62
IN - India 59
FI - Finlandia 54
CA - Canada 53
BD - Bangladesh 52
TR - Turchia 39
MX - Messico 32
JP - Giappone 30
NL - Olanda 28
AR - Argentina 27
DK - Danimarca 26
PL - Polonia 22
ZA - Sudafrica 21
ES - Italia 20
KR - Corea 19
MA - Marocco 19
IQ - Iraq 16
AT - Austria 15
EC - Ecuador 13
PK - Pakistan 13
VE - Venezuela 13
BE - Belgio 12
ID - Indonesia 11
CL - Cile 8
CO - Colombia 8
PH - Filippine 8
UZ - Uzbekistan 8
CR - Costa Rica 7
GT - Guatemala 7
PY - Paraguay 7
CW - ???statistics.table.value.countryCode.CW??? 6
HN - Honduras 6
NI - Nicaragua 6
SV - El Salvador 6
TT - Trinidad e Tobago 6
AU - Australia 5
LT - Lituania 5
SA - Arabia Saudita 5
TN - Tunisia 5
CU - Cuba 4
CZ - Repubblica Ceca 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
EG - Egitto 3
IL - Israele 3
JO - Giordania 3
KE - Kenya 3
LB - Libano 3
MY - Malesia 3
PE - Perù 3
RO - Romania 3
TH - Thailandia 3
AM - Armenia 2
AZ - Azerbaigian 2
BO - Bolivia 2
CH - Svizzera 2
ET - Etiopia 2
GE - Georgia 2
KZ - Kazakistan 2
NG - Nigeria 2
SC - Seychelles 2
SN - Senegal 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CG - Congo 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
GH - Ghana 1
GP - Guadalupe 1
JM - Giamaica 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
OM - Oman 1
PT - Portogallo 1
SI - Slovenia 1
TW - Taiwan 1
Totale 8.444
Città #
Ashburn 803
Dallas 404
Chandler 367
Des Moines 324
Singapore 310
San Jose 240
Council Bluffs 186
Hong Kong 173
New York 147
Dublin 146
Boardman 133
Ho Chi Minh City 122
Fairfield 117
Jacksonville 102
Hanoi 101
Los Angeles 80
The Dalles 79
Beijing 69
Lauterbourg 65
Abidjan 61
Wilmington 60
Princeton 57
Lawrence 53
Seattle 53
Woodbridge 53
Houston 46
Milan 45
Moscow 44
Munich 41
Cambridge 38
Santa Clara 36
Centro 35
Phoenix 34
San Mateo 34
Rome 33
São Paulo 29
Buffalo 28
Turin 28
London 24
San Diego 23
Turku 23
Hefei 22
Tokyo 21
Washington 21
Orem 20
Atlanta 19
Guangzhou 19
Helsinki 19
Warsaw 19
Da Nang 18
Chicago 17
Irvington 17
Denver 15
Haiphong 15
Columbus 14
Montreal 14
Redmond 14
Toronto 14
Ancona 13
Johannesburg 13
Pune 13
Shanghai 13
Boston 12
Frankfurt am Main 12
Rio de Janeiro 12
Ann Arbor 11
Baghdad 10
Brooklyn 10
Chennai 10
Stockholm 10
Curitiba 9
Mexico City 9
Pesaro 9
San Francisco 9
Urbisaglia 9
Brussels 8
Miano 8
Wuhan 8
Amsterdam 7
Brasília 7
Destin 7
Mumbai 7
Norwalk 7
Vienna 7
Calgary 6
Florence 6
Kolkata 6
Kyiv 6
Managua 6
Naples 6
Philadelphia 6
San Salvador 6
Tashkent 6
Vancouver 6
Willemstad 6
Belo Horizonte 5
Bắc Ninh 5
Charlotte 5
Clovis 5
Guarulhos 5
Totale 5.485
Nome #
Helicobacter pylori infection in psoriasis: results of a clinical study and review of the literature 231
The Role of Nutrition in Immune-Mediated, Inflammatory Skin Disease: A Narrative Review 202
Adalimumab modulates angiogenesis in psoriatic skin 180
Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review 176
Botulinum Toxin Type A for Treatment of Forehead Hyperhidrosis: Multicenter Clinical Experience and Review from Literature 165
Long-term efficacy and safety of apremilast in the treatment of plaques psoriasis: A real-world, single-center experience 161
Global coronavirus pandemic (SARS-CoV-2): Past, present, and future of pediatric dermatology 159
Activated switched memory B cell clusters in chronic spontaneous urticaria are increased in subjects with long disease duration and relapse upon omalizumab discontinuation: Results of the IL-10-OMZ study 158
Buschke–ollendorff syndrome in a 6-year old patient: Clinical anhistopathological aspects of a rare disease 156
Onabotulinumtoxin type A (Botox(®)) versus Incobotulinumtoxin type A (Xeomin(®)) in the treatment of focal idiopathic palmar hyperhidrosis: results of a comparative double-blind clinical trial 151
Research Strands in Dermatology and Gastroenterology Units of Department of Clinical and Molecular Sciences in Polytechnic Marche University 149
Effects of in vivo application of an overnight patch containing Allium cepa, allantoin, and pentaglycan on hypertrophic scars and keloids: Clinical, videocapillaroscopic, and ultrasonographic study 149
Skin Involvement in SARS-CoV-2 Infection: Case Series 148
The effect of low-carbohydrates calorie-restricted diet on visceral adipose tissue and metabolic status in psoriasis patients receiving TNF-alpha inhibitors: results of an open label controlled, prospective, clinical study 147
Mesenchymal Stem Cells Profile in Adult Atopic Dermatitis and Effect of IL4-IL13 Inflammatory Pathway Inhibition In Vivo: Prospective Case-Control Study 143
"BOTULINUM TOXIN IN DERMATOLOGY: A CLINICAL OVERVIEW" 143
Combined treatment of palmar hyperhidrosis with botulinum toxin type A and oxybutynin chloride: Results of a clinical, multicenter, prospective study 142
A Systematic Review of Atopic Dermatitis: The Intriguing Journey Starting from Physiopathology to Treatment, from Laboratory Bench to Bedside 141
Elastosis perforans serpiginosa: a case successfully treated with intralesional steroids and topical allium cepa-allantoin-pentaglycan gel 141
COVID 19-associated chilblain-like acral lesions among children and adolescents: an Italian retrospective, multicenter study 140
Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review 140
Contact allergy to SIDAPA baseline series allergens in patients with eyelid dermatitis: An Italian multicentre study 139
Vaccination against SARS-CoV-2 and psoriasis: the three things every dermatologist should know 138
Hidradenitis suppurativa in Crohn's disease during adalimumab therapy: a paradox? 137
Asymptomatic pigmentation of the skin in a child: babywipes, once again 137
Novel therapeutic approaches and targets for treatment of chronic urticaria: New insights and promising targets for a challenging disease 137
Primary cutaneous large cell lymphoma CD30+: a case-based review 136
Hidradenitis suppurativa: How to treat with BoNT-A 136
Treatment of palmar hyperhidrosis with botulinum toxin type A: results of a pilot study based on a novel injective approach. 135
Ingenol mebutate in actinic keratosis: A clinical, videodermoscopic and immunohistochemical study 133
Management of patients with pemphigus vulgaris during the COVID-19 pandemic: Experience of a second level dermatology center 133
Psoriatic patients treated with secukinumab reach high levels of minimal disease activity: results from the SUPREME study 133
Acne agminata in Crohn's disease: A diagnostic and therapeutic challenge case for dermatologists 131
Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy 131
Topical application of fumaric acid esters improves appearance of nail psoriasis 129
Photoprotection and photodermatitis: a case 128
Botulinum Toxin Off-Label Use in Dermatology: A Review 128
Italian Guidelines in patch testing - Adapted from the European Society of Contact Dermatitis (ESCD) 127
Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities 127
Safety update of etanercept treatment for moderate to severe plaque psoriasis 125
Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients 121
Acral Leukoderma: Is It Always Vitiligo? 120
Iperidrosi focale: novità terapeutiche 118
Time to restart: protocol of resumption of activities of a dermatological clinic of a level II hospital in the COVID-19 era 116
Psoriasis as an immune-mediated and inflammatory systemic disease: From pathophysiology to novel therapeutic approaches 112
Role of small intestinal bacterial overgrowth and helicobacter pylori infection in chronic spontaneous urticaria: a prospective analysis 111
Modern electronic devices: An increasingly common cause of skin disorders in consumers 107
Pain Control during the Treatment of Primary Palmar Hyperhidrosis with Botulinum Toxin A by a Topical Application of Liposomal Lidocaine: Clinical Effectiveness 103
It is never too late to treat chronic spontaneous urticaria with omalizumab: Real-life data from a multicenter observational study focusing on elderly patients 102
A tricky case of contact dermatitis: Simultaneous allergic reaction to topical and oral acyclovir, and scar gel 101
Pharmacodynamics of TNF α inhibitors for the treatment of psoriasis 100
How to fight SARS-COV-2 vaccine hesitancy in patients suffering from chronic and immune-mediated skin disease: four general rules 100
Omalizumab in Chronic Urticaria: An Italian Survey. 99
Contact allergy to hydrocortisone 21-acetate in Italy: A SIDAPA multicenter study 99
Mesenchymal Stem Cells and Psoriasis: Systematic Review 97
Saliva proteomics as fluid signature of inflammatory and immune mediated skin diseases 97
Myroxylon pereirae (balsam of Peru): Still worth testing? 97
Saliva and Oral Diseases 96
Hand eczema in Italian patients referred for patch testing: A retrospective SIDAPA study (2016–2023) 92
Two cases of Hidradenitis suppurativa and botulinum toxin type a therapy: A novel approach for a pathology that is still difficult to manage 90
Infliximab-induced eruptive sebaceous hyperplasia in patient treated for ulcerative colitis: first reported case 85
Preliminary experience with abrocitinib in severe atopic dermatitis 84
Patch testing of budesonide in Italy: The SIDAPA baseline series experience, 2018–2019 83
Late Patch Test Reaction to Acrylates in 2 Patients: Should We Schedule a Check at Weeks 2 and 3? 81
The pharmacological treatment and management of hyperhidrosis 76
The Challenge Arising from New Knowledge about Immune and Inflammatory Skin Diseases: Where We Are Today and Where We Are Going 69
Translation and pre-validation of the Quality of Life in Hand Eczema Questionnaire (QOLHEQ) in Italian 68
The new Italian SIDAPA Baseline Series for patch testing (2023): an update according to the new regulatory pathway for contact allergens 61
Treatment of Axillary Bromhidrosis with Topical 2% Glycopyrronium Bromide Cream: A Prospective, Non-randomized, Open-label Study 54
Totale 8.581
Categoria #
all - tutte 41.042
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.042


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022331 0 0 0 0 35 15 9 31 23 12 121 85
2022/20231.180 78 119 63 97 52 419 0 48 204 5 77 18
2023/2024604 86 11 58 66 86 172 10 16 6 20 11 62
2024/20251.241 150 92 22 26 41 30 103 46 308 86 169 168
2025/20263.640 306 211 379 293 399 210 624 290 314 334 111 169
2026/2027780 151 126 124 358 21 0 0 0 0 0 0 0
Totale 8.581